CX3CR1 sufficiency enhanced tumor cell CCL26 induction; this effect was attenuated by TGF-β1 blockade and reduced in Cx3cr1cKO PMN-MDSCs (Fig. 4L). The gene discussed is CCL26; the disease is neoplasm.